Hepatocyte transplantation for glycogen storage disease type Ib.
about
Glucose-6-phosphatase deficiencyNew potential cell source for hepatocyte transplantation: discarded livers from metabolic disease liver transplants.Neutropenia in type Ib glycogen storage diseaseThe history and use of human hepatocytes for the treatment of liver diseases: the first 100 patients.New Tools in Experimental Cellular Therapy for the Treatment of Liver Diseases.The use of cellular technologies in treatment of liver pathologies.Improvement of Infusion Process in Cell Transplantation: Effect of Shear Stress on Hepatocyte Viability Under Horizontal and Vertical Syringe Orientation.The SLC37 family of phosphate-linked sugar phosphate antiporters.Liver cell transplantation for the treatment of inborn errors of metabolism.Gallbladder epithelial cells that engraft in mouse liver can differentiate into hepatocyte-like cellsConsideration of a Safe Protocol for Hepatocyte Transplantation Using Infantile Pigs.Human hepatocyte transplantation: state of the art.Liver cell transplantation in children.Therapeutic hepatocyte transplant for inherited metabolic disorders: functional considerations, recent outcomes and future prospects.Therapeutic liver repopulation for phenylketonuria.Hepatocyte transplantation for inherited metabolic diseases of the liver.Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics.Concise review: cell therapies for hereditary metabolic liver diseases-concepts, clinical results, and future developments.Experimental hepatocyte xenotransplantation--a comprehensive review of the literature.Instant Blood-Mediated Inflammatory Reaction in Hepatocyte Transplantation: Current Status and Future Perspectives.Repopulation of human origin hepatocyte progenitor-like cell line, THLE-5b, in the SCID mouse liver under p21-mediated cell growth-arresting conditions.Hepatocyte transplantation improves phenotype and extends survival in a murine model of intermediate maple syrup urine disease.Noninvasive imaging of liver repopulation following hepatocyte transplantation.Hypothermic storage of human hepatocytes for transplantation.Hepatocyte transplantation (HTx) corrects selected neurometabolic abnormalities in murine intermediate maple syrup urine disease (iMSUD).An improvement in the attaching capability of cryopreserved human hepatocytes by a proteinaceous high molecule, sericin, in the serum-free solution.Hepatocytes from fibrotic liver possess high growth potential in vivo.Impaired hepatocyte regeneration in acute severe hepatic injury enhances effective repopulation by transplanted hepatocytes.Hepatocyte Transplantation in Special Populations: Clinical Use in Children.Human hepatocyte transplantation for liver disease: current status and future perspectives.Evaluation of drug-metabolizing and functional competence of human hepatocytes incubated under hypothermia in different media for clinical infusion.Hepatocyte transplantation: Consider infusion before incision.Alternative Cell Sources to Adult Hepatocytes for Hepatic Cell Therapy.Therapeutic liver repopulation for metabolic liver diseases: Advances from bench to bedside.Transplantation speed offers early hepatocyte engraftment in acute liver injured rats: A translational study with clinical implications.Human neonatal hepatocyte transplantation induces long-term rescue of unconjugated hyperbilirubinemia in the Gunn rat.Cell-based liver therapies: past, present and futureClinical Outcome of Hepatocyte Transplantation in Four Pediatric Patients with Inherited Metabolic Diseases
P2860
Q21202870-150C5D87-83F6-41AC-A8A4-8E4A7A69A7A4Q34673712-7696B06D-AD23-42C8-B85F-7A278F14A702Q34996563-BF723F96-032F-41DB-87A7-AB2BEAB4F3D7Q35129278-C6A8A9DA-A65D-49D4-A1A9-7B656ED04222Q35990789-30AAD734-C833-47C8-A22A-E7FFCF33606FQ36379723-FC9ECB35-69FB-484B-BD12-AE32CEBB857BQ36523489-35B45FA0-FB56-478A-A94A-973F9D403995Q36700318-F077DB0D-AA18-4E08-8E66-BB67318FE6FDQ37130112-C2D1B304-568E-4B2C-9E05-442AB57CC767Q37150769-11A24806-01EF-4983-A945-A322E747618FQ37541889-2047526B-34FE-484B-BCB3-454B1DE883A0Q37599928-63605902-A025-48D3-9C81-E29E1D6D3A72Q37636487-A0EA8F6F-37F9-433C-A148-9A2432A4555AQ37684677-634510EC-395F-4C3F-9C0B-7011FFD84F9CQ37760081-DBA7504A-507A-4BEF-98FD-9FDF29282B76Q38025743-78355078-D458-47C9-8263-E19BA681AB6DQ38263927-28FDA35C-BFD9-48C3-BDC6-AC257D471189Q38293985-B727DE55-5DA0-4CD2-96E6-7718B34E3EF6Q38463980-2B9B48F2-8ECF-487A-BD27-1C961A4C5C98Q38782397-B670D71D-1C0C-4828-9DC8-0C43025EA592Q39315062-015996D2-56AE-4429-BB88-752F9265A3FFQ39508625-EB91C27F-98EE-4D01-9BE0-87E0CA75A28FQ39976230-3FDD5901-E826-4482-A8F2-A4E4BF6C8FAFQ42440002-CBC39183-C006-4ABC-980D-25652FD58849Q42571919-5A6689F8-C3AA-45DA-93AD-29B40CDA3253Q43043903-B7126E32-2B77-4C39-B7F3-8E314C377C4BQ43272445-7297381E-8064-408A-A91C-1D15BEF794E6Q43299500-EFEAEEA9-A698-41CF-84CC-1B4D1B791B21Q45861729-CD1525AF-DA7F-45BC-972F-5E198472DCC7Q45874611-DD839957-D6F0-445E-83D7-F53C51E3F167Q46206520-6397EAA8-CCDB-4C9D-9793-7D0B9ABD7EDFQ48499059-FF3A1F2D-2DC2-42E8-9E61-236EC2820425Q48661191-0AEA9C5B-D7CA-4C50-95B0-E50B5C047961Q49083809-59CC3731-FD98-4D94-A0D4-FAAE0749A5D9Q50437536-089446C4-8022-4BE1-B9F0-FDCEE928A13DQ50449237-DBCEE1EA-1537-419D-83C0-9381FF1C6F9CQ57177119-7EC53700-EA2F-4ACA-8CB7-3FACF7AA5A0EQ58680778-B1503753-B7FE-46F0-A879-98FC12AE48CA
P2860
Hepatocyte transplantation for glycogen storage disease type Ib.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Hepatocyte transplantation for glycogen storage disease type Ib.
@en
Hepatocyte transplantation for glycogen storage disease type Ib.
@nl
type
label
Hepatocyte transplantation for glycogen storage disease type Ib.
@en
Hepatocyte transplantation for glycogen storage disease type Ib.
@nl
prefLabel
Hepatocyte transplantation for glycogen storage disease type Ib.
@en
Hepatocyte transplantation for glycogen storage disease type Ib.
@nl
P2093
P2860
P1433
P1476
Hepatocyte transplantation for glycogen storage disease type Ib.
@en
P2093
Doo-Hee Jung
Doo-Hoon Lee
Hee-Hoon Yoon
Hwa-Young Park
Hwan Hyo Lee
Ji-Hyun Lee
Jin Wan Park
Jong-Won Kim
Kwang-Woong Lee
Shi-Yeon Kim
P2860
P304
P356
10.3727/000000007783465019
P50
P577
2007-01-01T00:00:00Z